CDC Finalizes Vaccine Recommendation for Adults Traveling to Areas With Cholera
The Centers for Disease Control and Prevention (CDC)’s recommendation for the use of a cholera vaccine in adults traveling to areas with cholera is now final. The final recommendation was published today in CDC’s Morbidity and Mortality Weekly Report.
The vaccine, brand name Vaxchora, is a single-dose, live oral cholera vaccine and was approved by the U.S. Food and Drug Administration (FDA) in 2016 for prevention of cholera caused by serogroup O1. It is approved for use in adults 18 through 64 years old and is the only FDA-approved cholera vaccine in the United States. The federal Advisory Committee on Immunization Practices, composed of medical and public health experts, voted to recommend the vaccine in June 2016.
Most travelers from the United States do not visit areas with active cholera transmission and are rarely at risk. An area of active cholera transmission is defined as an area within a country where cholera is regularly found or where a cholera epidemic is ongoing. This includes areas with cholera activity within the past year prone to a cholera epidemic. This recommendation does not include areas where cases rarely have been reported.
Although cholera is rare, it can kill people quickly if it is not treated. All travelers going to areas with cholera should use and drink safe water, cook food thoroughly, and wash hands properly to prevent cholera infection. Travelers who develop severe diarrhea should seek medical attention, particularly therapy to restore lost fluids, as soon as possible.
More information on the recommendations and the evidence used to support them can be found at https://www.cdc.gov/mmwr/volumes/66/wr/mm6618a6.htm?s_cid=mm6618a6_w
Cholera is an acute, diarrheal illness caused by infection of the bacteria Vibrio cholerae. Additional information about cholera and cholera vaccine is available at http://www.cdc.gov/cholera/index.html.
Information about destinations with active cholera transmission is available at https://wwwnc.cdc.gov/travel/diseases/cholera.
Source: CDC
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.
